# Telmedicin sp. z o.o.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/telmedicin-sp-z-o-o

- Industry: Healthcare IT
- Headquarters: Warsaw, Poland
- Website: www.b2b.telemedi.co
- Total disclosed funding: $7.4M
- Latest round: Series A (Feb 1, 2021)
- Investors on record: 5

## About

Founded n 2013 and based in Warsaw, Poland, Telmedicin sp. z o.o., also known as Telemedico, operates as a software-as-a-service telemedicine platform for healthcare systems. The firm has more than 900,000 patients and 600 doctors providing remote consultations and has received total funding of EUR 6.2 million as of 2021.

Telemedico provides a telemedicine solution platform for patients that enables them to conduct medical consultations online. The platform's consultation allows patients to consult through chat, video, or telephone, AI-triaging and coordination, and booking of in-person visits and blood testing. Telemedico also supports consultation in different languages such as English, Spanish, Polish, Czech, Russian, Ukrainian, Serbian, Portuguese, Turkish, and Arabic.

The firm plans to use its recent funding for international expansion, expansion of supported languages, and is looking for potential growth opportunities in LatAm.

## Funding rounds

- Series A, Feb 1, 2021, $6.6M — UNIQA Group, PKO Bank Polski, Flashpoint, Balnord, Adamed Technology
- Seed, Jun 6, 2019, $0.8M — Balnord

## Investors

- Balnord — Seed, Series A
- UNIQA Group — Series A
- PKO Bank Polski — Series A
- Flashpoint (https://capitalatlas.ai/funds/flashpoint) — Series A
- Adamed Technology (https://capitalatlas.ai/funds/adamed-technology) — Series A